Literature DB >> 7049655

[Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies].

M Higi, N Niederle, K Bremer, G Schmitt, C G Schmidt, S Seeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7049655     DOI： 10.1055/s-2008-1070107

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  6 in total

Review 1.  Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

Authors:  M R Tramèr; D Carroll; F A Campbell; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  2001-07-07

2.  Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.

Authors:  H H Gerhartz; T Binsack; E Hiller
Journal:  Klin Wochenschr       Date:  1983-07-15

3.  [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].

Authors:  E Hiller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1984-05-15

4.  Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.

Authors:  N Niederle; J Schütte; C G Schmidt
Journal:  Klin Wochenschr       Date:  1986-04-15

5.  Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.

Authors:  M E Heim; W Queisser; H P Altenburg
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 6.  The therapeutic potential of cannabis and cannabinoids.

Authors:  Franjo Grotenhermen; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.